Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IIIb, Open, Randomised, Multicentre, Primary Study in Healthy Children, to Establish the Non-inferiority of GlaxoSmithKline (GSK) Biologicals' MeMuRu-OKA Vaccine (Administered at 9 and 15 Months of Age) Versus Priorix™ (9 Months of Age) and Priorix™ Co-administered With Varilrix™ at 15 Months of Age (Comparator) and Also to Evaluate the Non-inferiority of Priorix™ (9 Months of Age) and MeMuRu-OKA Vaccine (15 Months of Age) Versus the Comparator, All Administered Subcutaneously as Two-dose Primary Vaccination Course

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00969436
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:54.131563+00:00
Published At
2017-09-25T00:00:00+00:00
Record Updated At
2018-06-08
Results Posted At
2017-09-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Varicella", "Rubella", "Mumps", "Measles"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-06-08"
protocolSection.identificationModule.nctId
"NCT00969436"
protocolSection.identificationModule.officialTitle
"A Phase IIIb, Open, Randomised, Multicentre, Primary Study in Healthy Children, to Establish the Non-inferiority of GlaxoSmithKline (GSK) Biologicals\u0027 MeMuRu-OKA Vaccine (Administered at 9 and 15 Months of Age) Versus Priorix\u2122 (9 Months of Age) and Priorix\u2122 Co-administered With Varilrix\u2122 at 15 Months of Age (Comparator) and Also to Evaluate the Non-inferiority of Priorix\u2122 (9 Months of Age) and MeMuRu-OKA Vaccine (15 Months of Age) Versus the Comparator, All Administered Subcutaneously as Two-dose Primary Vaccination Course"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-09-25"

Study condition terms

  • Varicella (protocolSection.conditionsModule.conditions)
  • Rubella (protocolSection.conditionsModule.conditions)
  • Mumps (protocolSection.conditionsModule.conditions)
  • Measles (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.